computer translated:
Europa Press
Madrid
The vaccine Abdala against the coronavirus manufactured in Cuba shows 92.28 percent efficacy in clinical trials developed at the Center for Genetic Engineering and Biotechnology (CIGB) of the country.
Cuban President Miguel Díaz-Canel has reported the news through his Twitter account. "Hit by two pandemics (COVID-19 and the US blockade), our scientists have jumped over all obstacles and have given us two very effective vaccines: Sovereign 02 and Abdala."
This Sunday, Díaz-Canal announced that the other candidate vaccine produced in the country, Soberana 02, has an efficacy of 62 percent with two doses.
Given the results, the official press has reported that the request for emergency use will be made to the island's health authorities.
These news have come on the same day that the Cuban Ministry of Public Health has notified a new record of cases with 1,561 new cases and that exacerbates the upward trend of infections on the island, which accumulates almost 170,000 positives.
listindiario.com
The Abdala vaccine against the coronavirus manufactured in Cuba is 92% effective
|
Europa Press
Madrid
The vaccine Abdala against the coronavirus manufactured in Cuba shows 92.28 percent efficacy in clinical trials developed at the Center for Genetic Engineering and Biotechnology (CIGB) of the country.
Cuban President Miguel Díaz-Canel has reported the news through his Twitter account. "Hit by two pandemics (COVID-19 and the US blockade), our scientists have jumped over all obstacles and have given us two very effective vaccines: Sovereign 02 and Abdala."
This Sunday, Díaz-Canal announced that the other candidate vaccine produced in the country, Soberana 02, has an efficacy of 62 percent with two doses.
Given the results, the official press has reported that the request for emergency use will be made to the island's health authorities.
These news have come on the same day that the Cuban Ministry of Public Health has notified a new record of cases with 1,561 new cases and that exacerbates the upward trend of infections on the island, which accumulates almost 170,000 positives.

La vacuna candidata Abdala contra el coronavirus fabricada en Cuba presenta un 92% de eficacia
La vacuna candidata Abdala contra el coronavirus fabricada en Cuba presenta un 92,28 por ciento de eficacia en los ensayos clínicos d